Vanguard Capital Management’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
Vanguard Capital Management's PLSE Position: Q3 2026 in Review
Vanguard Capital Management increased its Pulse Biosciences (PLSE) stake by 19% in Q3 2026, buying an estimated $6.3M and bringing the position to 937,950 shares worth $46.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1924.
Vanguard Capital Management first reported a position in PLSE in Q1 2026 and has held it in 3 quarters since. 141 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Vanguard Capital Management held 937,950 shares of Pulse Biosciences worth $46.8M as of Q3 2026.
- Vanguard Capital Management bought 149,310 Pulse Biosciences shares in Q3 2026, an estimated $6.3M.
- Pulse Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1924 holding.
- Vanguard Capital Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 3 quarters since.
- 141 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.